0000899243-21-012738.txt : 20210319 0000899243-21-012738.hdr.sgml : 20210319 20210319161011 ACCESSION NUMBER: 0000899243-21-012738 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210317 FILED AS OF DATE: 20210319 DATE AS OF CHANGE: 20210319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thompson Alexis A. CENTRAL INDEX KEY: 0001851895 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37539 FILM NUMBER: 21758262 MAIL ADDRESS: STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC. STREET 2: 181 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER NAME: FORMER CONFORMED NAME: Thompson Alexis DATE OF NAME CHANGE: 20210317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-17 0 0001629137 Global Blood Therapeutics, Inc. GBT 0001851895 Thompson Alexis A. C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 44.28 2021-03-17 4 A 0 11200 0.00 A 2031-03-16 Common Stock 11200 11200 D Restricted Stock Units 2021-03-17 4 A 0 7200 0.00 A Common Stock 7200 7200 D The shares of Common Stock underlying the option vest in 36 equal monthly installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. This option is subject to accelerated vesting upon a change of control of the Issuer. Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in three equal annual installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon a change of control of the Issuer. /s/ Tricia Suvari, Attorney-in-Fact 2021-03-19